End stage liver disease/Cirrhosis Flashcards
Give me an overview of Cirrhosis and its causes
Late stage of progressive hepatic fibrosis with distortion of hepatic architecture and formation of regenerative nodules.
It is caused by alcoholism, viral hepatitis B and C, Metabolic liver disease, Hemochromatosis, Immune diseases (autoimmune hepatitis, primary billiary cirrhosis), Vascular disease (budd-chiari), DILI
Cirrhotic liver traits
Chronic, Irreversible, extensive fibrosis, regenerative nodules, Scarring
What are the signs and symptoms of cirrhosis?
Non specific Sx: anorexia, weight loss, weakness, fatigue
S/Sx of hepatic decompensation: Jaundice, Pruritis, upper GI bleeding, Ab. distention (Ascites), Confusion (Hepatic encephalopathy)
What physical examinations show the findings of cirrhosis?
What are some cirrhosis diagnostics?
What is a Fibroscan/Transient Elastography/FIB-4
Non invasive ultrasound methods that measure the amount of liver fibrosis
Describe the child pugh classification
Grades diseases severity, predicts long term risk of mortality and quality of life. Combination of physical and laboratory findings
Describe the Child Pugh Classification chart and what it means.
One- and two-year survival rate:
-A: 100 and 85%
-B 80 and 60%
-C 45 and 35%
Model for end stage liver disease score (MELD score)
Assess survival in patients with liver disease and prioritize organ allocation of cadaveric livers for transplantation
Uses serum, creatinine, bilirubin, INR, dialysis status, omitting ascities and encephalopathy
6 (less ill) to 40 (supa sick)
Compensated VS Decompensated Cirrhosis
Compensated:
-Asymptomatic
-Non specific Sx, fatigue, loss of appetite, weight loss
-May have elevated HVPG and varices, but not experience complication of variceal bleeding, ascites, SBP, or encephalopathy
Decompensated:
-Symptomatic
-Ascites (abdominal distention)
-HE (confusion, lethargy)
-Muscle wasting, palmar erythema
Median survival is shorten <1.6 years once patient develops a decompensating event
What is the overview of cirrhosis complications?
-PORTAL HYPERTENSION (hallmark)
-Increased vascular resistance
-Portosystemic collaterals
What causes portal hypertension complications?
Build of blood in scar tissue causes portal hypertension
Give me the overview of Portal HTN
Hepatic Venous Pressure gradient (HVPG) > 5 mmHg between portal & CNS = Portal Hypertension. This is associated with acute variceal bleeding
Clinical significant portal hypertension (CSPH), If HVPG >/= 10mmHg it increases risk of esophageal and gastric varices and bleeding (increase chance of decompensation)
What is the main goal of portal HTN and variceal bleeding treatment
Prevention of Bleeding and re-bleeding
What is the primary prophylaxis for variceal bleeding?
Screen for varices at the time of cirrhosis diagnosis
Non selective beta adrenergic blocking (NSBB): Main stay of treatment: Propranolol, nadolol, Carvedilol
Endoscopic variceal ligation (EVL): Endoscopic therapy by pacing rubber bands around varices: Alternative for patients who cannot take NSBBs (asthma or hypoglycemic)
Tell me the pearls of NSBBs
Not indicated for patients without varices
Medium to large varices that have not bled can recieve NSBB or EVL
NSBBs dose reduced or DC’d if persistent low SBP < 90 or severe adverse effects
-if low arterial pressure you can switch from carvedilol to propranolol or nadolol
Tell me what an NSBB does
Decreases cardiac output (B1 blockage)
Decrease portal flow by splanchnic arterial vasoconstriction (B2 blockage)
Decrease resistance by intrahepatic vasodilation (a1 blockage) - carvedilol only
What is the result of beta blocker treatment and what is the first line preferred?
Beta blockers have lower decompensation/death rate
Carvedilol achieves higher hemodynamic response and lower rebleeding than propranolol
Tell me everything you know about carvedilol in regards to portal hypertension.
Carvedilol causes intrahepatic vasodilation via nitric oxide release further decreasing portal pressure (a1 blockage)
-Significant decrease in HVPG compared to traditional NSBBs
-Not required titration
-More likely to cause systemic hypotension
-Preferred management for PH
Carvedilol 3.125 mg BID, titrate to max 6.25 BID
-titrate not guided by HR, only maintain SBP above 90 mmH
-greater HVPG reduction but higher potential to cause systemic hypotension
What should I monitor for betablockers? And the contraindications.
B blockers continue indefinitely, monitor renal impairment, hypotension, bradycardia, bronchospasm, hypoglycemia
Absolute contraindications:
Asthma, 2nd 3rd degree atrioventricular block (w/o pace maker), sick sinus syndrome, extreme bradycardia (<50 bpm)
Relative contraindications:
-Psoriasis, peripheral arterial disease, chronic obstructive pulmonary disease, pulmonary artery hypertension, insulin-dependent diabetes mellitus, Raynaud syndrome
Give me a summary of NSBBs used in PH
Tell me about acute variceal bleeding
How do you manage acute variceal bleeding?
Tell me about octreotide and what is it for
First line
Synthetic somatostatin analog, potent splanchnic vasoconstriction, decrease portal and collateral blood flow
Dose: Bolus 50 mcg IV then 50 mcg/hr infusion x 2-5 days
Side Effects: Hyperglycemia, Vomiting, bradycardia, hypertension, arrhythmia, diarrhea, and abd. pain
More effective in controlling acute bleeding